Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Default network activity is a sensitive and specific biomarker of memory in multiple sclerosis.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Letter to the Editor.
Do cortical lesions help us to distinguish MS from NMO?
Enhancement of Membrane B7-H3 Costimulatory Molecule but Reduction of Its Soluble Form in Multiple Sclerosis.
Managing MS: Trends, Issues, and Perspectives.
[Biomarkers in neuromyelitis optica].
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Afferent visual pathways in multiple sclerosis: a review.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Balo's Concentric Sclerosis with Acute Presentation and Co-Existing Multiple Sclerosis-Typical Lesions on MRI.
[Anti-NMDA receptor encephalitis - case report].
Neuroprotection With Phenytoin in Optic Neuritis
Glycans of myelin proteins.
Anatomical Brain Networks on the Prediction of Abnormal Brain States.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
230
231
232
233
234
235
236
237
238
…
next ›
last »